|
 |
Biotechnology for the Non-Biotechnologist |
Management Forum |
|
23-25 September 2009
Basel, Switzerland
The purpose of this training course is to provide non-biotechnologists with the basic theory to understand principles, techniques and the potentials of biotechnology.
Biotechnology combines disciplines such as molecular biology, biochemistry, chemistry, microbiology, chemical engineering and computing. This rapidly advancing science offers new and exciting opportunities to mankind, especially in the fight against disease.
Topics to be covered at this meeting:
Day One
- Introduction to Biotechnology
- Introduction to Molecular Biology
- Re-Expression of Proteins
- Development of Production Organisms
- Fermentation Technology and Large Scale Production
Day Two
- Process Optimisation and Scale-Up
- Analysis of Biopharmaceuticals
- Product Recovery and Purification
- Formulation Design of Biopharmaceuticals
- Process Economics
Day Three
- Patenting of Biotech Inventions
- Patent Workshop
- Regulatory Considerations
- Regulatory Applications and Consequences, Comparability and Equivalence
- Advances in Regulation: Biosimilars
- Current and Future Developments
Chairman - Dr Adekunle Onadipe - Associate Research Fellow, Bioprocess R&D Cell Line Development, Pfizer Inc.,USA |
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
Total Processing & Packaging 2010
25-27 May 2010, NEC Birmingham, UK
Total Processing & Packaging 2010 is the UK’s largest & most complete showcase of production line products showcasing machinery, equipment, materials and services to the UK processing and packaging industries.
More info >> |
|
 |
News and Press Releases |
 |
Doris Hafenbradl joins BioFocus as Senior Director, Biology and Natural Products
BioFocus, a leading provider of gene-to-drug candidate discovery services, recently announced that Dr. Doris Hafenbradl has joined BioFocus as Senior Director, Biology and Natural Products, based in Basel, Switzerland. Doris joins BioFocus from Proteros Biostructures where, as Executive VP, she was responsible for the strategic business and scientific development of the screening and proteins business unit.
More info >> |
|
|
